The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 414.00
Bid: 406.00
Ask: 414.00
Change: 6.00 (1.47%)
Spread: 8.00 (1.97%)
Open: 421.00
High: 421.00
Low: 407.00
Prev. Close: 408.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

End of the Programme & 28 Apr - 6 May Transactions

6 May 2022 15:29

RNS Number : 6667K
Banco Santander S.A.
06 May 2022
 

Banco Santander, S.A., in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

End of the Buy-back Programme

Reference is made to our notice of inside information of 14 March 2022 (official registry number 1360) relating to the buyback programme of own shares (the "Buy-back Programme" or the "Programme") approved by the Board of Directors of Banco Santander, S.A. (the "Company" or "Banco Santander"). Banco Santander informs that, after the last acquisitions mentioned below, the maximum investment provided for in the Buy-back Programme, i.e. 865 million euros was reached, implying the acquisition of a total of 286,309,445 own shares, representing approximately 1.676% of the Company's share capital. The acquisition of shares under the Buy-back Programme has been communicated on a regular basis, pursuant to the provisions of article 2.2 and 2.3 of the Commission Delegated Regulation (EU) No. 2016/1052. The Buy-back Programme has therefore been terminated as a consequence of the above and in accordance with the terms set out when it was announced.

As disclosed when the Buy-back Programme was launched, its purpose was to reduce the Bank's share capital by redeeming the shares acquired under the Buy-back Programme in a capital reduction approved at the 2022 Ordinary General Shareholders' Meeting.

Last transactions executed under the Programme. 

Moreover, pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, the Company informs that the transactions executed as part of the Buy-back Programme, between 28 April and 6 May 2022 (both included) were as follows:

 

Date

Security

Transaction

Trading venue

Number of shares

Weighted average price (€)

28/04/2022

SAN.MC

Purchase

XMAD

13,150,000

€2.7909

29/04/2022

SAN.MC

Purchase

XMAD

13,200,000

€2.7980

02/05/2022

SAN.MC

Purchase

XMAD

11,000,000

€2.7702

03/05/2022

SAN.MC

Purchase

XMAD

12,000,000

€2.8046

04/05/2022

SAN.MC

Purchase

XMAD

13,400,000

€2.8016

05/05/2022

SAN.MC

Purchase

XMAD

13,526,000

€ 2.7724

06/05/2022

SAN.MC

Purchase

XMAD

383,445

€2.6900

TOTAL

76,659,445

 

Issuer name: Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13

Reference of the financial instrument: ordinary shares - Code ISIN ES0113900J37

 

Detailed information of the transactions carried out within the referred period is attached as Annex I.

Boadilla del Monte (Madrid), 6 May 2022

 

ANNEX I

Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 28 April and 6 May 2022 (both included)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSAFMITMTTMBPT
Date   Source Headline
30th Jun 20205:23 pmRNSChanges in the composition of the Board
5th May 202011:49 amRNSDirector/PDMR Shareholding
4th May 20203:42 pmRNSDirector/PDMR Shareholding
28th Apr 20207:00 amRNS1Q2020 results report & analyst presentation
28th Apr 20207:00 amRNS1Q2020 results press release
27th Apr 20203:07 pmRNS1Q 2020 results presentation announcement
3rd Apr 202011:43 amRNS2020 AGM - Resolutions
3rd Apr 202011:40 amRNS2020 AGM - Press Release
3rd Apr 20207:00 amRNSCommunication from the auditor of Banco Santander
3rd Apr 20207:00 amRNSResolutions of the Board of Directors: Dividends
30th Mar 20207:00 amRNSRevision of the rating by Fitch
24th Mar 20207:00 amRNSCoranvirus: 2020 dividend & compensation
23rd Mar 20204:25 pmRNS2nd additional notice in relation to the AGM call
17th Mar 20207:52 amRNSSantander Group Chairman presentation at MS EFC
10th Mar 20204:06 pmRNSDirector/PDMR Shareholding
10th Mar 20207:51 amRNSAdditional notice in relation to the call to AGM
2nd Mar 20204:20 pmRNSDirector/PDMR Shareholding
2nd Mar 20209:00 amRNSDirector/PDMR Shareholding
28th Feb 20203:38 pmRNSNotice of AGM
28th Feb 20201:33 pmRNSAnnual Financial Report
27th Feb 20204:20 pmRNSAnnouncement: AGM Notice of call
26th Feb 20204:29 pmRNSForm 8.3 - Sophos Group Plc
19th Feb 20204:15 pmRNSForm 8.3 - Sophos Group plc
17th Feb 20205:23 pmRNSDirector/PDMR Shareholding
17th Feb 20205:21 pmRNSDirector/PDMR Shareholding
17th Feb 20205:19 pmRNSDirector/PDMR Shareholding
17th Feb 20205:12 pmRNSDirector/PDMR Shareholding
17th Feb 20205:11 pmRNSDirector/PDMR Shareholding
17th Feb 20205:10 pmRNSDirector/PDMR Shareholding
13th Feb 202010:00 amRNSPost Stabilisation Notice
5th Feb 20203:07 pmRNSForm 8.3 - Sophos Group Plc
4th Feb 20207:09 amRNSDirector/PDMR Shareholding
3rd Feb 202011:29 amRNSDirector/PDMR Shareholding
3rd Feb 20207:53 amRNSDirector/PDMR Shareholding
3rd Feb 20207:05 amRNSDirector/PDMR Shareholding
29th Jan 20207:00 amRNSPR: 2019 Results & Remuneration for shareholders
29th Jan 20207:00 amRNS2019 financial report & analyst presentation
28th Jan 20202:59 pmRNSNotice of Results
15th Jan 202012:36 pmRNSNotice of Early Redemption
15th Jan 20207:41 amRNSEarly redemption of CoCos (Irrevocable decision)
9th Jan 20206:10 pmRNSPlacement of preferred securities
9th Jan 202010:06 amRNSPre Stabilisation Notice
9th Jan 20208:12 amRNSIntention of Early Redemption
8th Jan 20205:52 pmRNSForm 8.3 - Sophos Group plc
30th Dec 20193:18 pmRNSDirector/PDMR Shareholding
27th Dec 20198:02 amRNSNewport - Amendment
19th Dec 20199:11 amRNSDirector/PDMR Shareholding
16th Dec 201910:08 amRNSDirector/PDMR Shareholding
16th Dec 20197:35 amRNSDirector/PDMR Shareholding
11th Dec 20198:17 amRNS2020 prudential minimum capital requirements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.